drugset / Trial / NCT03110679

Randomized Double-blind Study on the Treatment of Osteoarthritis of the Bilateral Knee: Autologous Bone Marrow Concentrate vs. Hyaluronic Acid

NCT03110679

Phase 4 Completed 60 enrolled Rizzoli Orthopaedic Institute
RandomizedParallel-groupDouble-blindTreatment

Summary

OA-bi-Blind is a randomized double-blind study on the treatment of osteoarthritis of the Bilateral knee: autologous bone marrow concentrate vs. hyaluronic acid.

Timeline

Start
2016-05-23
Primary completion
2016-11
Completion
2021-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 60 mg Other
Subject autologous bone marrow concentrate Cell therapy Other

Indications